[{"NetIncomeLoss_1_Q1_USD":-34051000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":10209000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":198835000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-893000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":33492000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":5470000.0,"AssetsCurrent_0_Q1_USD":319572000.0,"OperatingLeaseExpense_1_Q1_USD":1000000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q1_shares":3553000.0,"ContractWithCustomerLiability_0_Q1_USD":110037000.0,"AccountsReceivableGrossCurrent_0_Q1_USD":93000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":5510000.0,"CommonStockSharesIssued_0_Q1_shares":199941000.0,"Assets_0_Q1_USD":345962000.0,"ShareBasedCompensation_1_Q1_USD":3823000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":13648000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.01,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":33492000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.01,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"OperatingLeaseLiability_0_Q1_USD":20995000.0,"IncreaseDecreaseInOtherAccruedLiabilities_1_Q1_USD":3487000.0,"Liabilities_0_Q1_USD":251842000.0,"UnbilledReceivablesCurrent_0_Q1_USD":5405000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":34413000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":27180000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-480000.0,"CommonStockValue_0_Q1_USD":1999000.0,"InvestmentIncomeNet_1_Q1_USD":13000.0,"DebtInstrumentInterestRateStatedPercentage_0_Q1_pure":0.0005,"DepreciationDepletionAndAmortization_1_Q1_USD":551000.0,"RevenueRemainingPerformanceObligation_0_Q1_USD":110000000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":6185000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_1_Q1_USD":-1571000.0,"DebtInstrumentConvertibleNumberOfEquityInstruments_1_Q1_USD":501000.0,"PaymentsOfStockIssuanceCosts_1_Q1_USD":70000.0,"ConvertibleDebtCurrent_0_Q1_USD":2096000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-34051000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":3802000.0,"OtherAssetsNoncurrent_0_Q1_USD":7325000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":283120000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":17878000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":1458012000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":34778000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":3945000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":5490000.0,"CommonStockSharesAuthorized_0_Q1_shares":300000000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-44621000.0,"IncrementalCommonSharesAttributableToConversionOfDebtSecurities_1_Q1_shares":501000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":5389000.0,"LiabilitiesCurrent_0_Q1_USD":134353000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1_Q1_USD":-10736000.0,"AccountsPayableCurrent_0_Q1_USD":12916000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":15421000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":1286000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":32820000.0,"InterestExpenseDebt_1_Q1_USD":24000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.11,"SubleaseIncome_1_Q1_USD":1200000.0,"IncreaseDecreaseInOtherOperatingAssets_1_Q1_USD":-3661000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":397000.0,"NumberOfOperatingSegments_1_Q1_segment":1.0,"OperatingLeasePayments_1_Q1_USD":1400000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":0.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":5417000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":3674000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q1_USD":72000.0,"CommonStockSharesOutstanding_0_Q1_shares":199941000.0,"DeferredFinanceCostsCurrentNet_0_Q1_USD":4000.0,"OperatingIncomeLoss_1_Q1_USD":-28916000.0,"ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized_1_Q1_USD":72000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":51515000.0,"PreferredStockValue_0_Q1_USD":null,"LiabilitiesAndStockholdersEquity_0_Q1_USD":345962000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":2882000.0,"PreferredStockSharesAuthorized_0_Q1_shares":5000000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":3117000.0,"OperatingExpenses_1_Q1_USD":44622000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":7520000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.17,"OtherLiabilitiesNoncurrent_0_Q1_USD":2480000.0,"StockholdersEquity_0_Q1_USD":94120000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q1_USD":58522000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":893000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q1_USD":15706000.0,"VariableLeaseCost_1_Q1_USD":3100000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-1365891000.0,"MarketableSecurities_0_Q1_USD":0.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":58000.0,"ProfitLoss_1_Q1_USD":-34051000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":-72000.0,"Ticker":"IMGN","CIK":"855654","name":"IMMUNOGEN, INC.","OfficialName":"ImmunoGen Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1148965984.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210510"}]